I f you struggle with insomnia, a condition that causes trouble falling asleep, staying asleep, or both, it can have a profound impact on your quality of life, leading to fatigue, trouble ...

This chapter develops the efficacy and safety criteria of the currently available benzodiazepine and non-benzodiazepine hypnotics, as well as the characteristics that an ideal hypnotic should have.

When I discuss cognitive behavioral therapy for insomnia (CBTi) with patients, naturally their first question is “What is that?” My first response and the most important thing I can tell them is that ...

Sleep state misperception is a condition where you underestimate how much you’ve slept the night before. You may feel like you were awake all night, but you actually slept for hours. It’s also called ...

While insomnia is the most common sleep disorder, a lot of attention in the media is focused on sleep apnea because of its association with cardiovascular disease and diabetes. Variations in ...

TOKYO, May 28, 2025 - (JCN Newswire) - - Eisai Co., Ltd. announced today that the in-house-discovered and developed orexin receptor antagonist DAYVIGO (generic name: lemborexant) has been approved in ...

The duration of hypnotic pharmacological treatment in chronic insomnia is a very controversial issue. The Health Authorities of each country give recommendations limiting its duration to a few weeks.